tiprankstipranks
Trending News
More News >
Ligand Pharmaceuticals Inc (LGND)
:LGND
US Market
Advertisement

Ligand Pharma (LGND) Ratios

Compare
823 Followers

Ligand Pharma Ratios

LGND's free cash flow for Q2 2025 was $0.77. For the 2025 fiscal year, LGND's free cash flow was decreased by $ and operating cash flow was $0.26. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
24.69 14.15 2.67 11.15 5.00
Quick Ratio
24.30 12.72 2.53 10.50 4.74
Cash Ratio
21.76 1.37 <0.01 0.47 0.48
Solvency Ratio
0.08 1.03 0.23 0.21 0.04
Operating Cash Flow Ratio
1.81 2.95 1.40 1.89 0.55
Short-Term Operating Cash Flow Coverage
50.83 0.00 1.80 0.00 0.00
Net Current Asset Value
$ 227.32M$ 151.13M$ 98.42M$ -15.00M$ -152.20M
Leverage Ratios
Debt-to-Assets Ratio
0.31 <0.01 0.12 0.26 0.33
Debt-to-Equity Ratio
0.47 <0.01 0.15 0.41 0.64
Debt-to-Capital Ratio
0.32 <0.01 0.13 0.29 0.39
Long-Term Debt-to-Capital Ratio
0.32 0.00 0.00 0.28 0.38
Financial Leverage Ratio
1.55 1.12 1.28 1.58 1.92
Debt Service Coverage Ratio
22.70 138.71 0.17 7.65 2.79
Interest Coverage Ratio
19.84 18.20 -14.18 4.21 0.31
Debt to Market Cap
0.11 0.00 0.07 0.12 0.27
Interest Debt Per Share
23.33 0.39 5.31 21.35 29.78
Net Debt to EBITDA
-15.10 -0.17 1.61 2.38 5.89
Profitability Margins
Gross Profit Margin
19.20%73.31%73.08%77.56%83.68%
EBIT Margin
-29.95%48.98%19.27%33.13%15.40%
EBITDA Margin
5.63%76.79%27.72%48.05%37.04%
Operating Profit Margin
6.97%9.09%-13.00%28.47%4.59%
Pretax Profit Margin
25.07%48.48%18.35%17.07%-5.65%
Net Profit Margin
14.26%39.72%-2.66%20.62%-1.60%
Continuous Operations Profit Margin
-12.37%40.98%-2.66%27.55%3.54%
Net Income Per EBT
56.89%81.93%-14.49%120.80%28.33%
EBT Per EBIT
359.43%533.08%-141.20%59.95%-123.25%
Return on Assets (ROA)
2.43%6.63%-0.68%4.39%-0.22%
Return on Equity (ROE)
4.21%7.44%-0.87%6.95%-0.42%
Return on Capital Employed (ROCE)
1.21%1.55%-3.84%6.26%0.68%
Return on Invested Capital (ROIC)
1.80%1.31%0.50%7.62%0.19%
Return on Tangible Assets
3.14%16.46%-1.71%10.27%-0.53%
Earnings Yield
0.91%4.22%-0.46%2.22%-0.19%
Efficiency Ratios
Receivables Turnover
4.36 3.34 5.60 3.02 3.16
Payables Turnover
0.00 14.44 9.95 7.40 8.04
Inventory Turnover
3.62 1.46 3.97 2.28 1.15
Fixed Asset Turnover
22.68 5.24 13.08 8.46 8.20
Asset Turnover
0.17 0.17 0.26 0.21 0.14
Working Capital Turnover Ratio
0.50 0.68 0.67 0.67 0.25
Cash Conversion Cycle
184.35 333.61 120.35 231.79 388.06
Days of Sales Outstanding
83.63 109.27 65.17 120.70 115.64
Days of Inventory Outstanding
100.73 249.61 91.85 160.42 317.82
Days of Payables Outstanding
0.00 25.27 36.67 49.33 45.40
Operating Cycle
184.35 358.88 157.02 281.12 433.46
Cash Flow Ratios
Operating Cash Flow Per Share
2.86 2.87 8.17 4.74 3.37
Free Cash Flow Per Share
2.06 -0.25 7.11 4.21 3.10
CapEx Per Share
0.79 0.20 1.06 0.53 0.28
Free Cash Flow to Operating Cash Flow
0.72 -0.09 0.87 0.89 0.92
Dividend Paid and CapEx Coverage Ratio
3.60 14.08 7.69 8.99 12.24
Capital Expenditure Coverage Ratio
3.60 14.08 7.69 8.99 12.24
Operating Cash Flow Coverage Ratio
0.12 8.04 1.57 0.23 0.12
Operating Cash Flow to Sales Ratio
0.22 0.38 0.70 0.28 0.29
Free Cash Flow Yield
1.01%-0.35%10.64%2.73%3.11%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
109.45 23.69 -215.90 44.96 -539.23
Price-to-Sales (P/S) Ratio
15.79 9.41 5.74 9.27 8.63
Price-to-Book (P/B) Ratio
4.13 1.76 1.89 3.13 2.27
Price-to-Free Cash Flow (P/FCF) Ratio
99.26 -289.19 9.40 36.68 32.11
Price-to-Operating Cash Flow Ratio
70.84 24.92 8.17 32.60 29.49
Price-to-Earnings Growth (PEG) Ratio
0.68 -0.02 1.98 -0.02 5.36
Price-to-Fair Value
4.13 1.76 1.89 3.13 2.27
Enterprise Value Multiple
265.42 12.09 22.32 21.67 29.20
Enterprise Value
3.75B 1.22B 1.21B 2.89B 2.02B
EV to EBITDA
265.42 12.09 22.32 21.67 29.20
EV to Sales
14.94 9.28 6.19 10.41 10.82
EV to Free Cash Flow
93.92 -285.26 10.13 41.20 40.23
EV to Operating Cash Flow
67.82 24.58 8.81 36.62 36.94
Tangible Book Value Per Share
49.06 13.33 8.25 4.60 -5.34
Shareholders’ Equity Per Share
49.06 40.52 35.42 49.41 43.84
Tax and Other Ratios
Effective Tax Rate
-0.49 0.15 1.14 -0.22 0.72
Revenue Per Share
12.97 7.59 11.63 16.66 11.52
Net Income Per Share
1.85 3.02 -0.31 3.44 -0.18
Tax Burden
0.57 0.82 -0.14 1.21 0.28
Interest Burden
-0.84 0.99 0.95 0.52 -0.37
Research & Development to Revenue
0.33 0.19 0.18 0.25 0.32
SG&A to Revenue
0.37 0.40 0.36 0.21 0.35
Stock-Based Compensation to Revenue
0.21 0.20 0.31 0.14 0.16
Income Quality
-0.73 0.95 -4.13 1.38 -18.29
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis